DETERMINATION OF BETA-ADRENOCEPTOR SUBTYPE ON RAT ISOLATED VENTRICULAR MYOCYTES BY USE OF HIGHLY SELECTIVE BETA-ANTAGONISTS

Citation
Y. Kitagawa et al., DETERMINATION OF BETA-ADRENOCEPTOR SUBTYPE ON RAT ISOLATED VENTRICULAR MYOCYTES BY USE OF HIGHLY SELECTIVE BETA-ANTAGONISTS, British Journal of Pharmacology, 116(1), 1995, pp. 1635-1643
Citations number
33
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00071188
Volume
116
Issue
1
Year of publication
1995
Pages
1635 - 1643
Database
ISI
SICI code
0007-1188(1995)116:1<1635:DOBSOR>2.0.ZU;2-Q
Abstract
1 The relative proportions of beta(1)- and beta(2)-adrenoceptors were determined by radioligand binding studies in three different rat myoca rdial preparations: membranes prepared from rat ventricle (ventricular membranes), membranes prepared from rat isolated ventricular myocytes (myocyte membranes), and myocytes isolated from rat ventricle (myocyt es). 2 Competition experiments using CCP 20712A or ICI 118,551 with [I -125]-iodocyanopindolol ([I-125]-ICYP) revealed high- and low-affinity binding sites in ventricular membranes. The concentration at which ea ch beta-antagonist occupied 100% of its high-affinity binding sites wa s 300 nM for CGP 20712A (beta(1)-adrenoceptor) and 50 nM for ICI 118,5 51 (beta(2)-adrenoceptor). 3 The density of high-affinity (beta(1)-adr enoceptor) and low-affinity (beta(2)-adrenoceptor) binding sites for C GP 20712A was measured by a saturation experiment using [I-125]-ICYP i n the presence and absence of 300 nM CGP 20712A. In ventricular membra nes, the proportions of high-affinity and low-affinity binding sites f or CGP 20712A were 73% and 27%, respectively, whereas in myocyte membr anes, the corresponding figures were 90% and 10%, respectively. The de nsity of low-affinity binding sites for CGP 20712A in ventricular memb ranes, defined as [I-125]-ICYP-specific binding in the presence of 300 nM CGP 20712A, was decreased by addition of 50 nM ICI 118,551, wherea s that in myocyte membranes was not affected. 4 In myocytes, specific binding of [I-125]-ICYP and [H-3]-CGP 12177 was not detected by satura tion experiments performed in the presence of 300 nM CGP 20712A. 5 In myocytes, the activation of adenylate cyclase caused by beta(2)-adrena ceptors was not detected in the presence of 10 nM, 100 nM or 1000 nM C GP 20712A, which selectively antagonized beta(1)-adrenoceptors. Furthe rmore, the concentration-response curve for isoprenaline-stimulated cy clic AMP accumulation was not shifted by 10 nM or 100 nM ICI 118,551, which selectively antagonized beta(2)-adrenoceptors, but was shifted t o the right by 1000 nM ICI 118,551. 6 These results indicate that beta (2)-adrenoceptors are not present on rat ventricular myocytes and that beta(2)-adrenoceptor stimulation does not cause any detectable produc tion of cyclic AMP. We conclude that only beta(1)-adrenoceptors exist on rat ventricular myocytes.